Ann: Half Yearly Commentary, page-4

Good points those, thankfully with the human healthcare side performing, it appears all growth/additional studies in the Medivet business can be funded through existing cash-flows.
MrsB, I know 17m Revenue seems a bit of a stretch, however a couple larger deals in each of the remaining quarters, especially as a result of the new expanded  sales team, building on experience and client networks and I don't think it's too far fetched, but time will tell. Have to wait until end of April for the next Quarterly.



in other media:

Another positive stem cell news story posted  a couple days back:



And, the Pet Assoc annual report on spending. It goes to show how much money pet owners are willing to spend on their beloved pets and how even a small slice of the pie could be huge for Medivet:
http://www.seattletimes.com/business/as-pets-role-in-our-lives-grows-owners-spend-lavishly/



IMO, DYOR etc...